Nifty

:

23873.45

Sensex

:

76152.86

-41.00 (-0.17%)
-417.49 (-0.55%)

Login

Nifty
Sensex

:
:

23873.45
76152.86

-41.00 (-0.17%)
-417.49 (-0.55%)

Kilitch Drugs (India) Ltd.

Pharmaceuticals & Drugs

Rating :

68/99

BSE: 524500 | NSE: KILITCH

Watchlist

NSE BSE

172.52

03-Sep-2026

Open
High
Low
Previous Close

167
173.71
167
171.37

Volume
Traded Value (lacs)
52 Week High
52 Week Low

8770
1500588.18
219.5
117.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

599.77
19.94
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

671.70
N/A
2.13

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

23.45
15.57
15.11

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
28.87
9.00

PAT CAGR (%)

10 Years
5 Years
3 Years

-
32.60
27.34

P:E (Median)

8 Years
5 Years
3 Years

39.82
31.80
29.72

P:BV (Average)

8 Years
5 Years
3 Years

2.19
2.48
2.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.93
19.17
18.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 40.91 34.12 19.90% 71.97 56.30 27.83% 44.67 46.51 -3.96% 37.81 45.35 -16.63%
Expenses 36.27 30.55 18.72% 52.50 42.40 23.82% 38.95 38.39 1.46% 34.14 39.75 -14.11%
EBITDA 4.64 3.57 29.97% 19.47 13.90 40.07% 5.72 8.12 -29.56% 3.67 5.59 -34.35%
EBIDTM 11.35% 10.47% 27.05% 24.70% 12.81% 17.45% 9.71% 12.34%
Other Income 3.55 3.50 1.43% 1.14 2.33 -51.07% 1.61 2.37 -32.07% 7.61 5.81 30.98%
Interest 0.49 0.59 -16.95% 0.58 0.72 -19.44% 0.60 0.49 22.45% 0.68 0.42 61.90%
Depreciation 0.76 0.50 52.00% 0.70 0.51 37.25% 0.56 0.48 16.67% 0.53 0.40 32.50%
PBT 6.95 5.98 16.22% 19.33 15.00 28.87% 6.17 9.52 -35.19% 10.07 10.58 -4.82%
Tax 1.90 1.19 59.66% 5.33 3.63 46.83% 1.28 2.64 -51.52% 1.36 1.74 -21.84%
PAT 5.05 4.79 5.43% 14.00 11.37 23.13% 4.89 6.88 -28.92% 8.71 8.85 -1.58%
PATM 12.35% 14.05% 19.45% 20.20% 10.95% 14.80% 23.05% 19.51%
EPS 1.44 1.37 5.11% 4.00 3.25 23.08% 1.40 1.97 -28.93% 2.49 2.53 -1.58%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 44.88 43.14 4.03% 89.60 61.23 46.33% 53.81 56.17 -4.20% 48.92 47.48 3.03%
Expenses 41.94 39.88 5.17% 67.46 46.63 44.67% 47.66 47.43 0.48% 43.88 41.38 6.04%
EBITDA 2.94 3.26 -9.82% 22.14 14.59 51.75% 6.15 8.73 -29.55% 5.04 6.09 -17.24%
EBIDTM 6.54% 7.57% 24.71% 23.83% 11.43% 15.55% 10.30% 12.83%
Other Income 2.90 2.56 13.28% 0.49 1.70 -71.18% 1.53 1.73 -11.56% 6.66 5.16 29.07%
Interest 0.88 1.53 -42.48% 1.44 1.60 -10.00% 1.15 1.40 -17.86% 1.44 0.31 364.52%
Depreciation 1.09 0.84 29.76% 0.98 0.85 15.29% 0.94 0.81 16.05% 0.86 0.61 40.98%
PBT 3.86 3.45 11.88% 20.21 13.84 46.03% 5.60 8.25 -32.12% 9.40 10.35 -9.18%
Tax 1.90 1.19 59.66% 5.33 3.63 46.83% 1.28 2.64 -51.52% 1.36 1.74 -21.84%
PAT 1.97 2.26 -12.83% 14.88 10.22 45.60% 4.31 5.61 -23.17% 8.04 8.61 -6.62%
PATM 4.38% 5.24% 16.61% 16.69% 8.02% 9.99% 16.43% 18.14%
EPS 0.83 0.92 -9.78% 4.15 3.16 31.33% 1.27 1.81 -29.83% 2.34 2.62 -10.69%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 195.36 188.57 181.59 131.60 117.78 105.16 70.02 60.77 96.42 50.46 28.14 Net Sales Growth 7.18% 3.84% 37.99% 11.73% 12.00% 50.19% 15.22% -36.97% 91.08% 79.32% Cost Of Goods Sold 91.41 88.87 92.02 66.21 58.50 60.24 39.06 35.76 52.98 25.91 11.25 Gross Profit 103.95 99.70 89.57 65.38 59.29 44.92 30.95 25.02 43.43 24.55 16.88 GP Margin 53.21% 52.87% 49.33% 49.68% 50.34% 42.72% 44.20% 41.17% 45.04% 48.65% 59.99% Total Expenditure 161.86 155.41 150.47 111.18 100.45 94.03 64.69 59.60 80.82 44.88 28.71 Power & Fuel Cost - 2.61 2.61 2.36 2.15 2.00 1.63 1.68 1.47 1.14 1.09 % Of Sales - 1.38% 1.44% 1.79% 1.83% 1.90% 2.33% 2.76% 1.52% 2.26% 3.87% Employee Cost - 12.34 10.03 7.91 7.47 6.15 5.22 5.65 5.23 4.22 3.27 % Of Sales - 6.54% 5.52% 6.01% 6.34% 5.85% 7.46% 9.30% 5.42% 8.36% 11.62% Manufacturing Exp. - 6.95 5.52 4.69 5.37 5.91 3.65 3.55 2.88 2.18 2.59 % Of Sales - 3.69% 3.04% 3.56% 4.56% 5.62% 5.21% 5.84% 2.99% 4.32% 9.20% General & Admin Exp. - 30.24 26.58 20.78 15.51 5.83 5.69 6.25 4.38 2.65 2.17 % Of Sales - 16.04% 14.64% 15.79% 13.17% 5.54% 8.13% 10.28% 4.54% 5.25% 7.71% Selling & Distn. Exp. - 9.14 11.46 5.93 7.57 10.64 7.20 5.91 8.64 5.22 4.70 % Of Sales - 4.85% 6.31% 4.51% 6.43% 10.12% 10.28% 9.73% 8.96% 10.34% 16.70% Miscellaneous Exp. - 5.28 2.25 3.29 3.88 3.25 2.23 0.80 5.23 3.56 4.70 % Of Sales - 2.80% 1.24% 2.50% 3.29% 3.09% 3.18% 1.32% 5.42% 7.06% 12.86% EBITDA 33.50 33.16 31.12 20.42 17.33 11.13 5.33 1.17 15.60 5.58 -0.57 EBITDA Margin 17.15% 17.58% 17.14% 15.52% 14.71% 10.58% 7.61% 1.93% 16.18% 11.06% -2.03% Other Income 13.91 13.85 13.72 6.19 4.60 4.56 4.19 6.14 5.78 3.18 1.58 Interest 2.35 3.18 2.40 2.02 1.15 0.80 0.88 0.93 0.65 0.41 0.15 Depreciation 2.55 2.29 1.74 1.24 1.34 0.96 1.14 1.15 1.20 1.19 1.32 PBT 42.52 41.55 40.69 23.35 19.45 13.93 7.51 5.22 19.52 7.16 -0.46 Tax 9.87 9.15 9.53 5.78 3.73 3.40 1.35 0.77 4.76 0.96 -0.42 Tax Rate 23.21% 22.02% 23.42% 24.75% 19.18% 24.41% 17.98% 14.75% 24.39% 13.41% 91.30% PAT 32.65 32.40 31.16 17.57 15.72 10.53 6.16 4.46 14.77 6.20 -0.04 PAT before Minority Interest 32.65 32.40 31.16 17.57 15.72 10.53 6.16 4.46 14.77 6.20 -0.04 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.71% 17.18% 17.16% 13.35% 13.35% 10.01% 8.80% 7.34% 15.32% 12.29% -0.14% PAT Growth 2.38% 3.98% 77.35% 11.77% 49.29% 70.94% 38.12% -69.80% 138.23% - EPS 9.33 9.26 8.90 5.02 4.49 3.01 1.76 1.27 4.22 1.77 -0.01

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 237.21 235.47 198.32 154.37 139.60 114.23 68.52 53.32 82.49 51.01 28.65 Net Sales Growth 14.03% 18.73% 28.47% 10.58% 22.21% 66.71% 28.51% -35.36% 61.71% 78.05% Cost Of Goods Sold 125.12 126.14 104.58 78.96 74.76 65.43 37.31 29.09 48.17 26.00 11.25 Gross Profit 112.09 109.34 93.74 75.41 64.84 48.80 31.22 24.23 34.32 25.01 17.39 GP Margin 47.25% 46.43% 47.27% 48.85% 46.45% 42.72% 45.56% 45.44% 41.61% 49.03% 60.70% Total Expenditure 200.94 198.15 166.57 130.11 121.87 103.73 63.21 53.33 76.47 45.71 29.20 Power & Fuel Cost - 2.81 2.73 2.44 2.15 2.25 1.63 1.68 1.48 1.15 1.10 % Of Sales - 1.19% 1.38% 1.58% 1.54% 1.97% 2.38% 3.15% 1.79% 2.25% 3.84% Employee Cost - 14.31 11.32 10.01 11.73 6.18 5.24 5.69 5.28 4.30 3.38 % Of Sales - 6.08% 5.71% 6.48% 8.40% 5.41% 7.65% 10.67% 6.40% 8.43% 11.80% Manufacturing Exp. - 7.85 6.18 4.76 5.37 7.76 3.65 3.55 2.88 2.18 2.73 % Of Sales - 3.33% 3.12% 3.08% 3.85% 6.79% 5.33% 6.66% 3.49% 4.27% 9.53% General & Admin Exp. - 31.03 27.82 22.03 8.73 6.46 5.71 6.32 4.78 3.27 2.80 % Of Sales - 13.18% 14.03% 14.27% 6.25% 5.66% 8.33% 11.85% 5.79% 6.41% 9.77% Selling & Distn. Exp. - 10.31 11.69 6.20 14.81 11.42 7.22 6.20 8.64 5.22 4.71 % Of Sales - 4.38% 5.89% 4.02% 10.61% 10.00% 10.54% 11.63% 10.47% 10.23% 16.44% Miscellaneous Exp. - 5.71 2.25 5.71 4.32 4.22 2.44 0.80 5.24 3.59 4.71 % Of Sales - 2.42% 1.13% 3.70% 3.09% 3.69% 3.56% 1.50% 6.35% 7.04% 11.20% EBITDA 36.27 37.32 31.75 24.26 17.73 10.50 5.31 -0.01 6.02 5.30 -0.55 EBITDA Margin 15.29% 15.85% 16.01% 15.72% 12.70% 9.19% 7.75% -0.02% 7.30% 10.39% -1.92% Other Income 11.58 11.24 11.16 4.48 2.92 2.91 2.67 4.55 5.26 3.27 1.14 Interest 4.91 6.29 5.32 6.04 5.08 1.33 0.88 0.94 0.65 0.42 0.16 Depreciation 3.87 3.62 3.11 3.35 3.55 2.47 1.99 2.00 2.05 2.04 9.76 PBT 39.07 38.65 34.47 19.35 12.01 9.61 5.12 1.61 8.59 6.11 -9.32 Tax 9.87 9.15 9.53 5.78 3.73 3.40 1.35 0.77 4.76 0.96 -0.43 Tax Rate 25.26% 23.67% 27.65% 29.87% 31.06% 35.38% 26.37% 47.83% 55.41% 15.71% 4.61% PAT 29.20 30.17 26.70 14.61 10.45 7.36 3.67 0.84 3.83 5.15 -8.89 PAT before Minority Interest 30.06 29.50 24.94 13.58 8.28 6.21 3.77 0.84 3.83 5.15 -8.89 Minority Interest 0.86 0.67 1.76 1.03 2.17 1.15 -0.10 0.00 0.00 0.00 0.00 PAT Margin 12.31% 12.81% 13.46% 9.46% 7.49% 6.44% 5.36% 1.58% 4.64% 10.10% -31.03% PAT Growth 9.36% 13.00% 82.75% 39.81% 41.98% 100.54% 336.90% -78.07% -25.63% - EPS 8.34 8.62 7.63 4.17 2.99 2.10 1.05 0.24 1.09 1.47 -2.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 333.01 252.94 222.92 195.93 178.03 162.93 151.65 151.08 131.20 119.02 Share Capital 34.96 16.08 16.08 15.58 15.58 15.49 15.43 15.36 13.73 13.23 Total Reserves 297.69 236.51 206.49 174.99 159.59 147.09 135.02 134.60 113.72 104.41 Non-Current Liabilities 54.70 25.14 -2.39 -1.91 -1.23 -0.89 -0.57 -0.62 -1.55 -2.17 Secured Loans 58.60 27.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.68 0.25 0.17 0.07 0.28 0.38 0.39 0.41 0.00 0.00 Current Liabilities 107.17 77.20 64.37 56.42 53.99 32.53 22.08 20.53 14.17 10.92 Trade Payables 68.19 47.42 26.16 28.84 27.77 13.56 7.91 5.47 7.66 5.63 Other Current Liabilities 0.41 0.33 0.28 0.17 0.48 0.84 0.62 3.31 2.91 2.59 Short Term Borrowings 29.78 21.32 31.32 21.86 20.33 14.71 12.51 9.36 0.82 0.59 Short Term Provisions 8.78 8.12 6.61 5.55 5.41 3.43 1.04 2.40 2.78 2.11 Total Liabilities 494.88 355.28 284.90 250.44 230.79 194.57 173.16 170.99 143.82 127.77 Net Block 19.54 19.51 15.70 15.08 14.18 6.94 7.67 7.82 7.35 7.68 Gross Block 47.89 45.57 40.03 38.16 35.93 27.73 27.31 26.31 24.64 23.77 Accumulated Depreciation 28.35 26.07 24.33 23.08 21.75 20.78 19.64 18.49 17.29 16.09 Non Current Assets 288.73 192.90 143.42 135.68 133.07 122.81 117.13 106.78 81.97 79.71 Capital Work in Progress 140.02 47.29 5.96 1.31 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 71.89 71.85 71.27 71.10 70.15 70.10 70.27 71.24 70.25 70.31 Long Term Loans & Adv. 57.28 54.23 50.47 48.17 46.60 44.00 38.66 27.73 3.59 0.94 Other Non Current Assets 0.01 0.02 0.01 0.02 2.14 1.76 0.54 0.00 0.79 0.79 Current Assets 206.14 162.38 141.49 114.77 97.72 71.76 56.02 64.21 61.84 48.06 Current Investments 51.96 49.52 49.43 39.20 47.23 36.40 27.81 28.42 30.29 26.02 Inventories 11.52 15.31 3.99 2.04 5.00 3.59 5.56 4.72 2.80 2.60 Sundry Debtors 117.24 83.40 61.80 53.10 41.42 22.92 17.01 23.15 20.72 14.62 Cash & Bank 10.30 7.46 18.63 17.97 2.45 5.77 2.72 4.07 3.87 2.16 Other Current Assets 15.12 0.23 0.12 0.18 1.61 3.09 2.93 3.87 4.16 2.66 Short Term Loans & Adv. 14.82 6.47 7.52 2.28 1.54 3.04 2.89 3.71 3.80 2.66 Net Current Assets 98.98 85.18 77.11 58.35 43.73 39.23 33.94 43.68 47.67 37.14 Total Assets 494.87 355.28 284.91 250.45 230.79 194.57 173.15 170.99 143.81 127.77

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 279.65 202.33 176.29 151.60 139.09 127.13 118.25 121.06 112.03 101.20 Share Capital 34.96 16.08 16.08 15.58 15.58 15.49 15.43 15.36 13.73 13.23 Total Reserves 244.34 185.89 159.85 130.66 120.65 111.28 101.63 104.58 94.56 86.59 Non-Current Liabilities 54.70 25.14 -2.39 -1.91 -1.24 -0.90 -0.58 -0.62 -1.55 -2.47 Secured Loans 58.60 27.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.68 0.25 0.17 0.07 0.28 0.38 0.39 0.41 0.00 0.00 Current Liabilities 121.60 84.31 64.22 68.87 69.28 73.32 21.97 20.09 14.92 11.69 Trade Payables 79.65 54.16 25.59 40.87 42.87 53.65 7.10 4.35 7.72 5.68 Other Current Liabilities 3.06 0.33 0.28 0.25 0.57 1.41 1.22 3.89 3.50 3.22 Short Term Borrowings 30.11 21.65 31.65 22.19 20.43 14.80 12.61 9.45 0.92 0.69 Short Term Provisions 8.79 8.17 6.70 5.56 5.41 3.45 1.04 2.40 2.78 2.11 Total Liabilities 453.16 309.91 237.50 217.54 208.34 201.90 141.86 142.63 126.13 110.42 Net Block 66.65 64.41 61.98 64.22 64.54 29.96 31.53 32.13 32.96 33.31 Gross Block 123.80 117.93 112.39 111.28 108.05 71.01 70.59 69.19 67.97 66.28 Accumulated Depreciation 57.14 53.52 50.41 47.06 43.51 41.05 39.06 37.06 35.01 32.97 Non Current Assets 230.97 135.99 91.51 91.14 94.23 121.53 86.08 77.75 63.14 61.85 Capital Work in Progress 140.02 47.29 5.96 3.62 3.16 65.48 29.60 20.25 3.18 0.66 Non Current Investment 22.88 22.84 22.83 22.66 23.93 23.88 24.05 25.02 26.00 27.01 Long Term Loans & Adv. 1.41 1.42 0.72 0.62 0.46 0.44 0.36 0.34 0.22 0.08 Other Non Current Assets 0.01 0.02 0.01 0.02 2.14 1.76 0.54 0.00 0.79 0.79 Current Assets 222.20 173.92 145.99 126.40 114.10 80.36 55.79 64.88 62.98 48.57 Current Investments 51.96 49.52 49.43 39.20 47.23 36.40 27.81 28.42 30.29 26.02 Inventories 11.52 15.31 3.99 2.04 5.00 3.59 5.56 4.72 2.80 2.60 Sundry Debtors 120.18 84.74 63.22 54.29 41.41 22.92 15.86 19.44 20.69 14.61 Cash & Bank 16.78 9.85 19.64 19.98 10.06 12.50 2.80 7.94 4.77 2.29 Other Current Assets 21.75 6.50 1.71 0.54 10.40 4.96 3.77 4.37 4.43 3.05 Short Term Loans & Adv. 20.99 8.00 8.00 10.35 10.04 4.91 3.73 4.21 4.07 2.98 Net Current Assets 100.60 89.61 81.78 57.53 44.83 7.05 33.81 44.78 48.07 36.87 Total Assets 453.17 309.91 237.50 217.54 208.33 201.89 141.87 142.63 126.12 110.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 12.32 15.23 -2.58 6.10 5.21 6.13 7.29 7.42 -1.32 0.55 PBT 41.55 40.69 23.35 19.45 13.93 7.51 5.22 19.52 7.16 -0.46 Adjustment 0.89 -5.69 1.86 1.95 0.10 -0.46 -4.40 -2.81 -1.36 0.63 Changes in Working Capital -19.58 -11.30 -20.76 -10.97 -6.28 0.09 8.71 -5.12 -7.10 0.35 Cash after chg. in Working capital 22.86 23.70 4.45 10.43 7.74 7.14 9.54 11.59 -1.30 0.52 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -10.54 -8.47 -7.04 -4.33 -2.54 -1.01 -2.25 -4.18 -0.02 0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -96.00 -41.42 -8.71 6.24 -16.08 -5.35 -10.08 -21.90 -2.48 -0.86 Net Fixed Assets -95.05 -46.87 -6.52 -3.54 -8.20 -0.42 -1.00 -1.67 -0.87 -0.66 Net Investments -2.48 -0.67 -10.40 7.08 -10.88 -8.42 1.58 0.88 -4.21 -4.10 Others 1.53 6.12 8.21 2.70 3.00 3.49 -10.66 -21.11 2.60 3.90 Cash from Financing Activity 85.57 15.65 11.40 3.04 7.55 2.27 1.44 14.69 5.51 -0.04 Net Cash Inflow / Outflow 1.89 -10.54 0.11 15.39 -3.32 3.05 -1.35 0.20 1.71 -0.35 Opening Cash & Equivalents 7.41 17.95 17.84 2.45 5.77 2.72 4.07 3.87 2.16 2.52 Closing Cash & Equivalent 9.30 7.41 17.95 17.84 2.45 5.77 2.72 4.07 3.87 2.16

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 23.96 17.54 -1.53 2.59 5.78 45.66 4.46 0.29 1.42 1.12 PBT 38.65 34.47 19.35 12.01 9.61 5.12 1.61 8.59 6.11 -9.32 Adjustment 7.95 1.16 10.46 9.79 3.89 2.80 -1.23 1.87 2.03 11.49 Changes in Working Capital -12.11 -9.63 -24.31 -14.88 -5.19 38.75 6.33 -5.99 -6.70 -1.08 Cash after chg. in Working capital 34.50 26.01 5.50 6.92 8.32 46.67 6.71 4.47 1.44 1.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -10.54 -8.47 -7.04 -4.33 -2.54 -1.01 -2.25 -4.18 -0.02 0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -100.44 -39.95 -8.16 7.92 -15.25 -37.57 -10.45 -13.98 -4.45 -1.53 Net Fixed Assets -95.05 -46.87 -6.52 -3.54 -8.20 -0.42 -1.00 -1.67 -0.87 -0.66 Net Investments -2.48 -0.67 -10.40 7.08 -10.88 -8.42 1.58 0.88 -4.21 -4.10 Others -2.91 7.59 8.76 4.38 3.83 -28.73 -11.03 -13.19 0.63 3.23 Cash from Financing Activity 82.45 13.24 8.81 -0.72 7.03 1.61 0.85 16.86 5.51 -0.04 Net Cash Inflow / Outflow 5.97 -9.16 -0.88 9.78 -2.44 9.70 -5.14 3.17 2.48 -0.45 Opening Cash & Equivalents 9.80 18.96 19.85 10.06 12.50 2.80 7.94 4.77 2.29 2.75 Closing Cash & Equivalent 15.77 9.80 18.96 19.85 10.06 12.50 2.80 7.94 4.77 2.29

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 95.15 76.85 135.43 122.30 112.42 104.93 97.48 97.66 92.82 88.91 ROA 7.62% 9.73% 6.57% 6.53% 4.95% 3.35% 2.59% 9.38% 4.56% -0.03% ROE 11.07% 13.11% 8.51% 8.59% 6.23% 3.93% 2.97% 10.65% 5.06% -0.03% ROCE 12.37% 15.49% 10.75% 9.90% 7.83% 4.91% 3.79% 13.79% 6.01% -0.26% Fixed Asset Turnover 4.04 4.24 3.37 3.18 3.30 2.55 2.27 3.79 2.09 1.20 Receivable days 194.18 145.93 159.35 146.46 111.66 103.82 120.51 83.03 127.36 200.64 Inventory Days 25.97 19.39 8.37 10.92 14.90 23.78 30.83 14.22 19.43 33.78 Payable days 237.42 145.93 151.58 176.61 125.20 100.28 44.43 33.10 60.51 70.99 Cash Conversion Cycle -17.28 19.39 16.14 -19.23 1.36 27.32 106.91 64.15 86.28 163.43 Total Debt/Equity 0.27 0.19 0.14 0.11 0.12 0.09 0.08 0.06 0.01 0.00 Interest Cover 14.08 17.92 12.59 17.93 18.52 9.57 6.61 31.26 18.45 -1.99

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 79.89 61.45 107.06 93.85 87.43 81.82 75.85 78.11 78.86 75.44 ROA 7.73% 9.11% 5.97% 3.89% 3.03% 2.19% 0.59% 2.85% 4.36% -7.86% ROE 12.26% 13.20% 8.43% 5.86% 4.73% 3.09% 0.71% 3.36% 4.95% -8.59% ROCE 14.50% 17.31% 13.30% 10.26% 7.26% 4.40% 1.95% 7.59% 6.08% -8.69% Fixed Asset Turnover 1.95 1.72 1.38 1.27 1.28 0.97 0.76 1.20 0.76 0.44 Receivable days 158.82 136.16 138.92 125.11 102.77 103.03 120.72 88.79 125.86 197.00 Inventory Days 20.79 17.76 7.13 9.21 13.72 24.29 35.14 16.62 19.22 33.17 Payable days 193.60 139.16 153.61 204.43 269.21 297.22 42.27 32.14 59.43 52.58 Cash Conversion Cycle -13.99 14.76 -7.56 -70.11 -152.72 -169.89 113.59 73.27 85.65 177.59 Total Debt/Equity 0.32 0.24 0.18 0.15 0.15 0.12 0.11 0.08 0.01 0.01 Interest Cover 7.14 7.48 4.21 3.36 8.22 6.84 2.71 14.25 15.68 -58.98

Top Investors:

dipak kanayalal shah

investor education and protection fund authority

mukul mahavir agrawal

premilaben rameshchandra shah

Annual Reports:

News Update:

Kilitch Drugs commences Nutraceutical Manufacturing Block at Raigad plant
17th Jun 2026, 15:43 PM

The company has commenced the same on June 17, 2026
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback